EXPERIENCES WITH PRICE COMPETITION OF BIOSIMILAR DRUGS IN HUNGARY

被引：0
|
作者：
Hornyak, L. [1 ]
Nagy, Z. [2 ]
Talos, Z. [1 ]
Agoston, I [2 ]
Endrei, D. [2 ]
Csakvari, T. [3 ]
Boncz, I [4 ]
机构：
[1] Csolnoky Ferenc Hosp, Veszprem, Hungary
[2] Univ Pecs, Pecs, Hungary
[3] Univ Pecs, Zalaegerszeg, Hungary
[4] Univ Pecs, Fac Hlth Sci, Pecs, Hungary
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.1018
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP83
引用
收藏
页码：A418 / A418
页数：1
相关论文
共 50 条
  • [41] THE PRICE OF COMPETITION
    WEINBERG, C
    TEACHERS COLLEGE RECORD, 1965, 67 (02): : 106 - 114
  • [42] Toward affordable cancer drugs: Do we need firmer price negotiation, me-too drugs, or a biosimilar silver bullet?
    Fundytus, Adam
    Sullivan, Richard
    Booth, Christopher M.
    SEMINARS IN ONCOLOGY, 2020, 47 (06) : 353 - 354
  • [43] Immigrants - Experiences in Hungary
    Buda, B
    PREVENTING MENTAL ILLNESS: MENTAL HEALTH PROMOTION IN PRIMARY CARE, 1998, : 337 - 342
  • [44] Diabetes Drugs: List Price Increases Were Not Always Reflected In Net Price; Impact Of Brand Competition Unclear
    Sarpatwari, Ameet
    Tessema, Frazer A.
    Zakarian, Marie
    Najafzadeh, Mehdi N.
    Kesselheim, Aaron S.
    HEALTH AFFAIRS, 2021, 40 (05) : 772 - 778
  • [45] NEW PRICE SYSTEM IN HUNGARY
    CSIKOSNAGY, B
    ACTA OECONOMICA, 1979, 23 (3-4) : 235 - 245
  • [46] Hungary - price guidelines set
    不详
    INTERNATIONAL SUGAR JOURNAL, 2000, 102 (1223): : 594 - 594
  • [47] Nonprescription drugs in Hungary
    Fabian, L
    Vincze, Z
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (10) : 1207 - 1207
  • [48] PRICE AND NON-PRICE COMPETITION
    STIGLER, GJ
    JOURNAL OF POLITICAL ECONOMY, 1968, 76 (01) : 149 - 154
  • [49] PRICE-COMPETITION AT ANY PRICE
    DORGE, FW
    NIEBISCH, A
    GEGENWARTSKUNDE GESELLSCHAFT STAAT ERZIEHUNG, 1984, 33 (01): : 81 - 90
  • [50] Biosimilar drugs in oncology: characteristics and insights
    Cascinu, Stefano
    CLINICAL MANAGEMENT ISSUES, 2013, 7 (02) : 39 - 40
12345